Search research articles
Contact Us
Filters
Showing results (11-20 of 449) with videos related to
Page
of 45
Sort By:
Chest
|
April 7, 2011
Up in smoke: the fallacy of the harmless Hookah
Andrew Chan, Susan Murin
European Journal of Neurology
|
September 22, 2022
The borderland of multiple sclerosis and functional neurological disorder: A call for clinical research and vigilance
Selma Aybek, Andrew Chan
Nature Clinical Practice. Neurology
|
August 26, 2006
Can pathological patterns be used to guide individualized multiple sclerosis therapy?
Andrew Chan, Ralf Gold
Journal of Neurology
|
May 16, 2007
Neuropsychological/-psychiatric deficits in immune-mediated neuropathies
Andrew Chan, Ralf Gold
Analytica Chimica Acta
|
August 29, 2007
Capillary electrophoresis for capture and concentrating of target nucleic acids by affinity gels modified to contain single-stranded nucleic acid probes
Andrew Chan, Ulrich J Krull
Neurological Research and Practice
|
December 16, 2020
Navigating choice in multiple sclerosis management
Ralf A Linker, Andrew Chan
Neurodegenerative Disease Management
|
April 4, 2022
Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap
Andrew Chan, Carlos Vila Silván
Current Pharmaceutical Design
|
May 23, 2012
Therapeutic monitoring of immunotherapies in autoimmune diseases
Nicolas von Ahsen, Andrew Chan
The Journal of Clinical Investigation
|
May 8, 2009
How can we improve the translational landscape for a faster cure of type 1 diabetes?
Matthias von Herrath, Andrew Chan
Neurology
|
April 17, 2013
Mitoxantrone-related acute leukemia in MS: an open or closed book?
Andrew Chan, Francesco Lo-Coco
Page
of 45
Search research articles
Search
Showing results (11-20 of 449) with videos related to
Sort By:
Page
of 45
Chest
|
April 7, 2011
Up in smoke: the fallacy of the harmless Hookah
Andrew Chan, Susan Murin
European Journal of Neurology
|
September 22, 2022
The borderland of multiple sclerosis and functional neurological disorder: A call for clinical research and vigilance
Selma Aybek, Andrew Chan
Nature Clinical Practice. Neurology
|
August 26, 2006
Can pathological patterns be used to guide individualized multiple sclerosis therapy?
Andrew Chan, Ralf Gold
Journal of Neurology
|
May 16, 2007
Neuropsychological/-psychiatric deficits in immune-mediated neuropathies
Andrew Chan, Ralf Gold
Analytica Chimica Acta
|
August 29, 2007
Capillary electrophoresis for capture and concentrating of target nucleic acids by affinity gels modified to contain single-stranded nucleic acid probes
Andrew Chan, Ulrich J Krull
Neurological Research and Practice
|
December 16, 2020
Navigating choice in multiple sclerosis management
Ralf A Linker, Andrew Chan
Neurodegenerative Disease Management
|
April 4, 2022
Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap
Andrew Chan, Carlos Vila Silván
Current Pharmaceutical Design
|
May 23, 2012
Therapeutic monitoring of immunotherapies in autoimmune diseases
Nicolas von Ahsen, Andrew Chan
The Journal of Clinical Investigation
|
May 8, 2009
How can we improve the translational landscape for a faster cure of type 1 diabetes?
Matthias von Herrath, Andrew Chan
Neurology
|
April 17, 2013
Mitoxantrone-related acute leukemia in MS: an open or closed book?
Andrew Chan, Francesco Lo-Coco
Page
of 45